LLY vs WAT · P/E 39, rev $22.97B vs P/E 32, rev $3.17B
Eli Lilly and Company (LLY) versus Waters Corporation (WAT) — a side-by-side from cached financials, not a winner call.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Latest reported WAT revenue for 2025-12-31 was $3.17B. Net income was $642.6M. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
LLY currently screens at market cap $991.62B and trailing P/E 39.5. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Not investment advice. Open the LLY and WAT stock pages for the full models.
Not investment advice.